Lamond David bought QNCX
June 11, 2026 · Form 4 insider transaction
Lamond David bought 2,700 shares of Quince Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,700
Price
$0.00
Total value
N/A
InsiderLamond David
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 15, 2026
Shares owned after2,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.